FDA proposes changes in iron product packaging

Rosendahl, Iris
November 1994
Drug Topics;11/7/94, Vol. 138 Issue 21, p77
Trade Publication
Reports on the Food and Drug Administration's (FDA) proposed new regulations affecting high-potency iron products. Labeling requirements; Protection of children who are prone to misuse the drugs; Cooperation of the Nonprescription Drug Manufacturers Association with the FDA.


Related Articles

  • FDA Defends Drug Review Proces Despite Criticisms From HRG.  // Chemical Market Reporter;04/05/99, Vol. 255 Issue 14, p17 

    Reports the decline in the rate of withdrawal of drugs in the United States (US). Reaction of the Public Citizen's Health Research Group concerning the US Food and Drug Administration's drug approval process; Concerns that caused the withdrawal of Redux, Posicor and Duract drugs in the market;...

  • Simplify, simplify. Horton, Kathleen // Pharmaceutical Executive;Sep97, Vol. 17 Issue 9, p154 

    Reports on the Nonprescription Drug Manufacturers Association's reaffirmation of its support to the US Food and Drug Administration proposal to standardize, and simplify all nonprescription and over-the-counter labels. Concerns of NDMA about meeting the 6-point type size label requirement;...

  • S.C. pharmacy group to partner with RxPatrol.  // Drug Topics;6/21/2004, Vol. 148 Issue 12, p12 

    This article reports on the plan of the South Carolina Pharmacy Association to hold a press conference on June 30, 2004 to announce that its RxAlert program is partnering with Purdue Pharma's RxPatrol. Rx Alert, launched in October 2003 is a daily fax and electronic mail program for registered...

  • Untitled.  // DCI;Nov93, Vol. 153 Issue 5, p10 

    Reports on the regulation issued by the Food and Drug Administration placing identification codes in nonprescription oral solid dosage forms. Initiative from the Nonprescription Drug Manufacturers Association; Consumer education campaign by the Consumer Product Safety Commission.

  • Medication risk videoconference postponed.  // Medical Marketing & Media;Jan2002, Vol. 37 Issue 1, p32 

    Reports the decision of Food and Drug Administration and Drug Information Association to postpone its videoconference in the U.S.

  • NDMA seeks OTC inactive ingredient rule. Dickinson, James G. // Medical Marketing & Media;Mar1998, Vol. 33 Issue 3, p33 

    Focuses on the Nonprescription Drug Manufacturers Association in the United States. Implementation of the Food and Drug Administration Modernization Act; Details on what was required by formal regulations.

  • Pharmaceutical manufacturers offer plan to reform the FDA. Rankin, Ken // Drug Store News;7/24/95, Vol. 17 Issue 11, p9 

    Reports on the proposal by the Pharmaceutical Research and Manufacturers of America (PhRMA) on reforming the US Food and Drug Administration (FDA). Features of the proposal; Role of FDA advisory panels in the plan; Previous FDA reform proposals by Republican Party members in the US House.

  • Small-pack OTCs. Conlan, Michael F. // Drug Topics;1/5/98, Vol. 142 Issue 1, p19 

    Reports that the Nonprescription Drug Manufacturers Association's (NDMA) request to reopen the comment period on a possible exemption from proposed over-the-counter labeling requirements for small packages is under consideration by the United States Food and Drug Administration (FDA). What the...

  • PCMA champions NDC number.  // Drug Topics;12/8/2003, Vol. 147 Issue 23, p14 

    Reports on the move of Pharmaceutical Care Management Association to urge the U.S. Food and Drug Administration not to charge the structure of NDC numbers as part of the agency's bar code initiative.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics